Department of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & *
|
|
- Frederick Norton
- 6 years ago
- Views:
Transcription
1 Indian J Med Res 122, October 2005, pp Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases Vikas Manchanda, N.P. Singh, R. Goyal, A. Kumar & S.S. Thukral * Department of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & * V.P. Chest Institute, University of Delhi, Delhi, India Received August 12, 2004 Background & objectives: Identifying organisms that harbour extended spectrum beta lactamases (ESBLs) is a major challenge for a diagnostic clinical microbiology laboratory. Wide variety of ESBLs produced and lack of a sensitive phenotypic method for their detection make the detection of ESBLs difficult and is responsible for under-recognition. The present study was undertaken to evaluate phenotypic characteristics, initial screening tests and established confirmatory phenotypic methods for detection of ESBLs Klebsiella pneumoniae isolates prevalent in a hospital in north India. Methods: One hundred, non-repeat clinical isolates of K. pneumoniae collected over a period of six months were included in the study. Susceptibilities of the isolates to 20 different antimicrobial agents were determined. Agar dilution and broth dilution methods were used to determine minimum inhibitory concentrations (MICs) of ceftazidime (CAZ) and cefotaxime (CTX). CAZ and CTX were used with and without clavulanic acid to detect ESBL harbouring isolates. Using agar dilution and broth dilution, MIC reduction of two and three doubling dilutions were evaluated as a criterion for ESBL harbouring isolates. Standard double disk synergy test (DDST) with disks placed at 30mm and modified DDST with disks placed at 16mm center-to-center distance, using at least two different third generation cephalosporins and combined disk method were also performed to detect ESBL harbouring isolates. Results: Multi-drug resistance (resistance to three or more antimicrobials of different classes) was found among 94 per cent of the isolates. Pooling the results of all the three confirmatory techniques MIC reduction of > 3 doubling dilutions using broth dilution method (using CTX and CAZ), combined disk method [(using CTX, ceftriaxone [(CRO), CAZ and aztreonam)] and standard DDST (using CTX, CRO, CAZ and aztreonam), revealed as many as 87 per cent of the isolates as ESBL producers. CTX had greater sensitivity in identifying isolates that harboured ESBLs. Modified DDST using CTX was as sensitive method as broth dilution method and combined disk method in detecting ESBL harbouring isolates. MIC reduction technique using agar dilution method and standard DDST had lowest overall sensitivity in detecting ESBLs. Interpretation & conclusion: Modified DDST using at least two different third generation cephalosporins was considered to be the best technique for detection of ESBL producing K. pneumoniae at our hospital. MIC reduction test with > 2 doubling dilution reduction in MICs was found to be a better criterion than the presently recommended > 3 doubling dilution reduction. For screening of potential ESBL producers, MIC determination using agar dilution was as good as that using broth dilution method. However, while performing MIC reduction test agar dilution method was found highly unreliable for detection of ESBL harbouring isolates. Key words Double disk synergy test - ESBLs - K. pneumoniae - MIC reduction test 330
2 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 331 Despite the fact that there are large numbers of Gram negative clinical isolates that harbour extended spectrum beta lactamases (ESBLs), very few clinical laboratories routinely perform ESBL detection, especially in developing countries, due to costs involved, work load and extra labour. Efforts have been made for detection and interpretation of ESBLs among clinical isolates and various cut off points of disk diffusion and minimum inhibitory concentrations (MICs) have been described 1-3. A key problem in the detection of ESBL producers is the possibility of low level expression of enzyme and of inoculum effect, resulting in variable MIC values and zone diameters by disk diffusion testing. Although different enzymes of TEM- and SHV- class show some patterns in antibiogram, the enzymes differ in the level of resistance conferred to different antimicrobial compounds. Therefore, specific detection methods such as the double disk synergy test (DDST), combined disk method, E-test and three-dimensional methods have been described 1,4-6. Different studies have reported greater sensitivity or reliability of detection of one method over the other as well as the success of particular antimicrobial substrates. Of these methods, it is still impractical to use E test for detection of ESBLs on routine basis in diagnostic laboratories because of forbidden cost in developing countries. Moreover, difficulty in interpretation of E test has been reported in some cases due to 'phantom effect' 7,8. Threedimensional test is still evolving 9. In an earlier study different phenotypic techniques using well-characterised ESBL harbouring isolates have been compared and the investigators have emphasized to extend similar studies to the various clinical isolates 8. Detection rates for a particular method generally vary with the types of ESBLs produced and the geographical area where these clinical isolates are prevalent. Therefore, standardization of the techniques needs to be done to exploit the method for maximal detection of ESBL producers without false positive or negative results. Many studies from India have reported occurrence of ESBLs in various members of Enterobacteriaceae using different phenotypic methods The present study was carried out to evaluate phenotypic characteristics of clinical isolates of Klebsiella pneumoniae in a tertiary care hospital in north India and to determine the best phenotypic technique for detection of ESBLs among the clinical isolates. Material & Methods One hundred consecutive, non-repeat clinical isolates of K. pneumoniae obtained from various clinical specimens sent to microbiology laboratory at University College of Medical Sciences and Guru Tegh Bahadur Hospital, Delhi during March and August 2001 were included in the study. The isolates were identified with standard biotyping methods 20. Of these neonatal intensive care unit (NICU) contributed to 19 isolates, and 31 isolates each were recovered from wound swabs from burns unit, and samples from various sites in patients admitted to inpatient units. Samples from outpatients contributed 18 isolates. One isolate was recovered from a patient in ICU. Antimicrobial susceptibilities of the isolates to 20 different antimicrobial agents (µg) viz. cefoperazone, (75) ceftazidime (CAZ), (30) cefotaxime (CTX) (30) aztreonam (ATM) (30) ceftriaxone (CRO) (30) cefepime, (30), cefoxitin (30), cefotetan, (30) cotrimoxazole (1.25/23.75) amikacin, (30) gentamicin, (10) kanamycin, (30) ciprofloxacin, (5) chloramphenicol, (30) pipracillin, (100) pipracillin + tazobactam, (100/10) amoxycillin + clavulanate, (20/10), loracarbef (30) imipenem (10) and netilmicin (30) were determined by standard disk diffusion (SDD) using commercially available disks (Oxoid, Basingstoke, UK) and were categorized as sensitive, intermediate and resistant as per National Committee for Clinical Laboratory Standards (NCCLS) guidelines wherever applicable 1. Quality control was achieved by using standard strain of Escherichia coli ATCC NCCLS recommendations to identify potential ESBL producing isolates using standard disk diffusion technique were followed, i.e., zone sizes of < 22mm, < 27mm, < 27mm and < 25mm for CAZ, ATM, CTX and CRO respectively, were taken to identify potential ESBL harbouring isolates 1. MICs of CAZ and CTX for these isolates were determined by the agar dilution and broth dilution methods using series of dilutions containing the antimicrobial (CAZ or CTX) alone (final concentrations
3 332 INDIAN J MED RES, OCTOBER 2005 of mg/ml), and with 4mg/ml clavulanic acid (CA; Ranbaxy, India). MIC cut-off points for ESBL producers were taken according to the NCCLS recommendations, isolates with MICs > 2mg/ml for CAZ, and MICs > 8mg/ml for CTX were identified as potential ESBL producers 1. The MIC reduction of two times and three times doubling dilutions were assessed for cut-off to be taken as ESBL phenotype. Standard and modified double disk synergy test (DDST) was performed using disks of 30 mg each of CAZ and CTX along with AMCA (amoxycillin 20 mg x clavulanic acid 10 mg). The disks were placed at the distance 30 and 16 mm from each other (centre to centre) and incubated at 37 0 C overnight 12. The organism was considered habouring ESBLs if the zone of inhibition around the CAZ and/or CTX disk showed a clear cut increase towards the AMCA disk 4,12. Combined disk method was used as recommended by the NCCLS 1. One disk each of CAZ/CA (30 /10mg) and CTX/CA (30/10mg) were applied to the surface of the inoculated plate. A disk each of CAZ and CTX were also applied. A 5mm increase in zone diameter for either antimicrobial agent tested in combination with CA versus its zone when tested alone was taken as an indication of ESBL producing isolates. Quality control was achieved using E. coli ATCC and K. pneumoniae ATCC Criteria for confirmed ESBL phenotype: When the isolate was found to harbour ESBL by atleast two of the three confirmatory criteria that included MIC reduction of > 3 doubling dilutions using broth dilution method (using CTX and CAZ), combined disk method (using CTX, CRO and CAZ), and DDST (using CTX, CRO and CAZ) with 30 mm distance center-to-center between the two disks, it was labeled as confirmed ESBL phenotype. Results & Discussion All the isolates were found susceptible to imipenem (Table I). Multi drug resistance (resistance to three or more antimicrobials of different classes) was found among 94 per cent of the isolates. Six isolates that were not multi drug resistant were all ESBL non-producers. Also, 59 of the total isolates were resistant to all the tested third generation cephalosporins (3GC) and aztreonam. Among non-beta-lactam agents, chloramphenicol and co-trimoxazole were the two antimicrobials against which maximum ESBL harbouring isolates were found susceptible (Table II). Susceptibility to aminoglycosides was found low among the ESBL producers ranging between 6-20 per cent. Among all the isolates studied 37.9 per cent were found resistant to the piperacillin+tazobactam combination while all isolates were found susceptible to carbapenems studied. The reasons for this pattern are not known. None of the ESBL harbouring isolates was sensitive to combination of amoxycillin and clavulanic acid (Table II). An association was found between aztreonam and gentamcin resistance and ESBL production. Isolates that were resistant to gentamicin and aztreonam harboured ESBLs but not all the ESBL harbouring isolates were resistant to the two antimicrobials. No other association between antimicrobial susceptibility and ESBL production could be identified. Using standard disk diffusion (SDD) as screening method for identifying potential ESBL producers, ceftriaxone was the most efficient antimicrobial in screening isolates as potential ESBL producers followed by CTX (Table III). Ceftriaxone missed three ESBL harbouring isolates. Cefotaxime and aztreonam missed seven and nine ESBL harbouring isolates respectively. Ceftazidime was the least efficient among these four antimicrobials missing 14 isolates that were later identified as harbouring ESBLs. MICs determined using agar dilution and broth dilution methods revealed similar results. The detailed distribution of MICs of the isolates for ceftazidime and cefotaxime is shown in Fig.1 and 2. Among ESBL harbouring isolates MICs of <2mg/ml was found in nine isolates for CAZ and MICs of < 8mg/ml was observed in five of these isolates for CTX Minimum inhibitory concentrations of < 1mg/ml was observed among four ESBL producing isolates (one isolate for CTX and three isolates for CAZ). ESBL producing K. pneumoniae may have higher MICs against antimicrobials compared with those of ESBL non-producing isolates. Since these elevated MICs to CAZ do not reach the NCCLS recommended break point levels for potential ESBL producers
4 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 333 (>2mg/ml), therefore, such isolates may be incorrectly dismissed as ESBL non-producing isolates 1. The isolates having high MICs of oxyimino beta-lactam agents can be labeled as potential ESBL producers. In the present study, nine isolates could not meet the NCCLS criteria for potential ESBL producers. Moreover, MICs of four ESBL harbouring isolates were < 1 mg/ml. Some other workers have also reported similar findings 22,23. It has been shown that amino acid substitutions in Klebsiella ESBLs can results in such MIC changes. However, none of the Indian studies has reported ESBL producing K. pneumoniae with MICs of < 2 mg/ml 13,14. Therefore, great caution is needed in interpreting the MICs cut-off for ESBL harbouring isolates. Using MIC reduction test as confirmatory test for detection of ESBL producing isolates, with > 3 doubling dilution MIC reduction criterion for ESBL producers, CTX detected greater number of ESBL harbouring isolates than CAZ. However, use of > 2 doubling dilution MIC reduction criterion increased the sensitivity of detection of ESBL harbouring isolates (Table IV). The extra isolates that were detected by modified criterion (> 2 doubling dilution MICs reduction) were also confirmed as harbouring ESBLs using combined disk method and standard double disk synergy test. When standard DDST (30mm distance center-tocenter) was used as confirmatory test for detection of ESBL producing isolates, maximum of 22 isolates were detected as ESBL producers using CRO. However, reducing the distance to 16mm center-to-center markedly increased the sensitivity of the test (Table IV). CTX and CRO detected maximum number of ESBL harbouring isolates followed by aztreonam and ceftazidime. The results obtained by the combined disk method revealed similar results CTX and CRO were better antimicrobials for detection of ESBL harbouring isolates than aztreonam and CAZ. Pooling the results of all the three confirmatory techniques MIC reduction of > 3 doubling dilutions using broth dilution method (using CTX and CAZ), combined disk method (using CTX, CRO, CAZ and aztreonam), and DDST (using CTX, CRO, CAZ and aztreonam) with 30 mm distance center-to-center Table I. Antimicrobial susceptibility profiles of all Klebsiella pneumoniae isolates included in the study Drug No. of isolates Sensitive Intermediate Resistant Amikacin Amoxycillin + Clavulanate Aztreonam Cefepime Cefoperazone Cefotaxime Cefotetan Cefoxitin Ceftazidime Ceftriaxone Chloramphenicol Ciprofloxacin Cotrimoxazole Gentamicin Imipenem Kanamycin Loracarbef Netilmicin Piperacillin Piperacillin + Tazobactam
5 334 INDIAN J MED RES, OCTOBER 2005 between the two disks, revealed as many as per 87 per cent of the isolates as ESBL producers. CTX had greater sensitivity in identifying isolates that harboured ESBLs. Modified DDST using CTX was as sensitive as broth dilution method and combined disk method in detecting ESBL harbouring isolates. MIC reduction technique using agar dilution method and standard DDST (30mm distance center-to-center) had lowest overall sensitivity in detecting ESBLs. The distance between disks is critical for each enzyme, as the test depends on the concentration of both beta-lactam antibiotic and inhibitor. Several attempts may be required to detect an ESBL producer. Several modifications, including the choice of drugs tested and varying the distance between the disks, have been recommended 4-6. We tried different distances viz., 30, 20, 16 and 14mm for detection of ESBL harbouring isolates. Best results were obtained by using at 16mm distance center-to-center between the two disks (unpublished data). Increasing the distance further between the two disks resulted in missing a large number of ESBL harbouring isolates. On the other hand, decreasing the distance further interfered with the interpretation of the results. A study from India also used 16 mm distance and reported good results 12. Several workers from India and other countries have used 30, 25, 21 and 20mm distance between the disks and few have labeled the method as inadequate for detecting all the ESBL producing isolates 4,5,11,24,25. In the present study, use of cefotaxime and ceftriaxone in the DDST resulted in the detection of a larger number of ESBLs harbouring isolates than ceftazidime. The results were similar to the combined disk method currently recommended by the NCCLS. Thus, for laboratories that perform susceptibility testing by disk diffusion, modified DDST could be easily incorporated into an already existing system. It has the added benefit that there is no need to measure zone sizes hence removing the subjectivity and is easy to read by recording presence or absence of synergy. Further, it requires no extra time in setting up the test and reading it. MIC reduction of > 2 or > 4 fold has been used in the past 6,14,26. It is important to note that three additional isolates identified by using > 2 doubling dilution Table II. Susceptibility profiles of extended spectrum b-lactamase (ESBL) producing Klebsiella pneumoniae Drug Sensitive Intermediate Resistant n (%) n (%) n (%) Amikacin 16 (18.3) 5 (5.7) 66 (75.8) Amoxycillin + Clavulanate (100) Aztreonam 13 (14.9) 12 (13.7) 62 (71.2) Cefepime 42 (48.2) 25 (28.0) 20 (22.9) Cefoperazone 13 (14.9) 1(0.01) 73 (83.9) Cefotaxime 14 (16.0) 10 (11.4) 63 (72.4) Cefotetan 69 (79.3) 0 18 (20.6) Cefoxitin 51 (58.6) 10 (11.4) 16 (18.3) Ceftazidime 21 (24.1) 07 (08.0) 59 (67.8) Ceftriaxone 10 (11.4) 13 (14.9) 64 (73.5) Chloramphenicol 40 (45.9) 4 (04.5) 43 (49.4) Ciprofloxacin 17 (19.5) 7 (8.0) 63 (72.4) Co-trimoxazole 25 (28.0) 13 (14.9) 49 (56.3) Gentamicin 17 (19.5) 0 70 (80.4) Imipenem 87 (100) 0 0 Kanamycin 5 (5.7) 0 82 (94.2) Loracarbef 51 (58.6) 31 (35.6) 5 (5.7) Netilmicin 25 (28.7) 0 62 (71.2) Piperacillin (100) Piperacillin + Tazobactam 12 (13.7) 42 (48.2) 33 (37.9)
6 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 335 Minimum inhibitory concentration (mg/ml) Fig.1. Minimum inhibitory concentrations (MICs) distribution of cefotaxime among all the clinical isolates of K. pneumoniae included in the study. Minimum inhibitory concentration (mg/ml) Fig.2. Minimum inhibitory concentrations (MICs) distribution of ceftazidime among all the clinical isolates of K. pneumoniae included in the study. reduction criterion were later confirmed by standard DDST and combined disk method as ESBL producers. Further studies are needed to confirm these findings. Our findings showed that modified DDST has an added advantage over the combined method since it is easier to perform and quick to interpret. In our study, the modified DDST was found as good as MIC reduction test using broth dilution in detection of ESBL producers. A study from Turkey has reported MIC reduction as a better technique than standard DDST for the detection of ESBL harbouring isolates 27. Table III. Comparison of methods used for screening and identification of extended spectrum b-lactamases (ESBLs) MIC reduction DDST Antimicrobials SDD MIC* > 2 doubling > 3 fold doubling Combined for dilutions dilutions disk method screening Agar Broth Agar Broth 16 mm 30 mm dilution dilution dilution dilution Cefotaxime (> 8mg/ml) Ceftazidime (> 2 mg/ml) Ceftriaxone 84 ND ND ND ND ND Aztreonam 78 ND ND ND ND ND *MICs determined using agar and broth dilution produced exactly similar results for CTX and CAZ ND, not determined; SDD, standard disk diffusion; MIC, minimum inhibitory concentration, DDST, double disk synergy test. All figures are in percentages
7 336 INDIAN J MED RES, OCTOBER 2005 Table IV. Sensitivities of extended spectrum b-lactamase (ESBL) confirmatory tests for different antimicrobials MIC reduction Antimicrobials > 2 doubling > 3 fold doubling DDST Combined dilutions dilutions disk method Agar Broth Agar Broth 16 mm 30 mm dilution dilution dilution dilution Cefotaxime Ceftazidime Ceftriaxone ND ND ND ND Aztreonam ND ND ND ND ND, not determined. Other abbreviations same as in Table III. All figures are in percentages Sensitivity of particular test using an antimicrobial was calculated using number of isolates identified as ESBL producer using that particular method and antimicrobial divided by total number of ESBL harbouring isolates that were identified using three standard method It was observed that when used alone, CAZ was able to detect lesser number of the ESBL producing isolates as compared to CTX by all the three confirmatory techniques. Combination of two or more techniques increased the detection rate of ESBL producers. It is important to note that for screening of potential ESBL producers MIC determination using broth dilution was as good as that using agar dilution method. However, while performing MIC reduction test agar dilution method was found highly unreliable for detection of ESBL harbouring isolates. The material, labour and cost involved may preclude the use of MIC reduction test for detection of ESBL harbouring isolates in routine clinical laboratories. To conclude, modified DDST using at least two different 3GCs was the best technique for detection of ESBL producing K. pneumoniae at our hospital. MIC reduction test with > 2 doubling dilution reduction in MICs was found to be a better criterion than the presently recommended > 3 doubling dilution reduction. Our observations suggested that additional testing to detect ESBL production in the clinical isolates on a routine basis, would be necessary to institute appropriate antibiotic therapy. References 1. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 10th Informational Supplement, Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards Document M100-S10; D' Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenovar F. The molecular and clinical epidemiology of enterobacteriaceae-producing extendedspectrum beta-lactamase in a tertiary care hospital J Infect 1998; 36 : Dandekar PK, Barrett NL, Nightingale CH, Nicolau DP. Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from Conn Med 2003; 67 : Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10 : Thomson KS, Sanders CC. Detection of extended spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother 1992; 36 : Cormican MG, Marshall SA, Jones RN. Detection of extendedspectrum beta-lactamase (ESBL)-producing strains by the E test ESBL screen. J Clin Microbiol 1996; 34 : Bradford PA. Extended spectrum beta-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14 : MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV- derived extended - spectrum beta-lactamase detection. Clin Microbiol Infect 2002; 8 : Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur
8 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 337 Hospital, Delhi, India. J Antimicrob Chemother 2003; 51 : Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003; Subha A, Ananthan S. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002; 20 : Ananthakrishanan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum beta-lactamase producers among surgical wound infectons and burns patiens in JIPMER. Indian J Med Microbiol 2000; 18 : Hansotia JB, Agarwal V, Pathak AA, Saoji A M. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105 : Abigail S, Mathai E, Jesudason MV, John TJ. Ceftazidime resistance among Klebsiella pneumoniae in south India Indian J Med Res 1995; 102 : Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary care hospital Indian J Med Microbiol 2004; 22 : Revathi G, Singh S, Singh S. Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J Med Microbiol 1997; 15 : Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing Gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115 : Khurana S, Taneja N, Sharma M. Extended spectrum betalactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 2002; 116 : Shahid M, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inculation method and modified three-dimensional extract test: comparison with the conventional threedimensional extract test J Antimicrob Chemother 2004; 54 : Crichton PB. Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera. In: Collee, I G, Fraser A G, Marmion, B P, Simmons A, editors. Mackie & McCartney practical medical microbiology, 14th ed. Edinburgh, UK: Churchill Livingstone, 1996; p Jorgensen JH, Turnidge JD. Susceptibility testing methods: Dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Jorgenson JH, Yolken RH, editors. Manual of clinical microbiology, 8th ed VA, USA: ASM Press 2003; p West PW. Extended spectrum beta-lactamase producing Klebsiella spp. Br J Biomed Sci 2000; 57 : Yuan M, Aucken H, Hall LM, Pitt TL, Livermore DM. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother 1998; 41 : Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum b-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35 : Coudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a Veterans medical center: seek and you may find. J Clin Microbiol 1997; 35 : Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of a novel, inhibitor-potentiated disk-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 1998; 42 : Kocazeybek BS. Antimicrobial resistance surveillance of Gramnegative isolated from intensive care units of four different hospitals in Turkey. Evaluation of the prevalence of extendedspectrum and inducible beta-lactamases using different E-test strips and direct induction methods. Chemotherapy 2001; 47 : Reprint requests: Dr N.P. Singh, Department of Microbiology, University College of Medical Science & Guru Tegh Bahadur Hospital Dilshad Garden, Delhi , India manchandavikas@hotmail.com
Occurrence of TEM & SHV gene in extended spectrum b-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital
Indian J Med Res 125, February 2007, pp 173-178 Occurrence of TEM & SHV gene in extended spectrum b-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital Prabha Lal, Arti Kapil,
More informationIOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. VII (Oct. 2017), PP 76-81 www.iosrjournals.org Molecular Characterization of TEM, SHV
More informationDetection and characterization of extended spectrum β-lactamase producing Escherichia coli from poultry of eastern India
Detection and characterization of extended spectrum β-lactamase producing Escherichia coli from poultry of eastern India Dr. Samiran Bandyopadhyay Scientist Indian Veterinary Research Institute Eastern
More informationEvaluation of a 12 Disc Test for Phenotypic Detection of β- lactamases Resistance in Gram Negative Bacilli
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 6 (2016) pp. 105-114 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.506.013
More informationUse of Molecular Assays for Resistance Detection
Use of Molecular Assays for Resistance Detection Antimicrobial resistance and susceptibility are complex, and current in vitro methods have been developed to predict a microorganism s response to antibacterial
More informationOccurrence and Detection of AmpC β-lactamases among Enterobacteriaceae in a Tertiary Care Centre in Trivandrum, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.023
More informationAre There Non-Carbapenem β-lactam Options for Treating ESBL Infections?
CIDEIM Are There Non-Carbapenem β-lactam Options for Treating ESBL Infections? Pranita D. Tamma, M.D., M.H.S. Assistant Professor, Pediatrics Director, Pediatric Antimicrobial Stewardship Program CIDEIM
More informationOriginal article DOI: Journal of International Medicine and Dentistry 2016; 3(1): 34-41
Original article DOI: http://dx.doi.org/10.18320/jimd/201603.0134 JOURNAL OF INTERNATIONAL MEDICINE AND DENTISTRY To search..to know...to share p-issn: 2454-8847 e-issn: 2350-045X Comparative analysis
More informationSUMMARY. Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M,
SUMMARY Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M, The doctoral thesis entitled Prevalence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBL) isolated from broilers
More informationExtended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay
Original Article Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay Meher Rizvi, Nazish Fatima, Mohd. Rashid, Indu Shukla, Abida Malik, Aayesha
More informationCME/SAM. Clinical Laboratory Detection of AmpC β-lactamase Does It Affect Patient Outcome?
Microbiology and Infectious Disease / Laboratory Detection of AmpC β-lactamase Clinical Laboratory Detection of AmpC β-lactamase Does It Affect Patient Outcome? Kenneth H. Rand, MD, 1 Bradley Turner, MD,
More informationINTRODUCTION. Original Article
Chattagram Maa-O-Shishu Hospital Medical College Journal Original Article Comparison Between Phenotypic Confirmatory Test & Double Disc Synergy Test in Detection of Extended Spectrum β-lactamases Producers
More informationKey words: ESBLs; Ceftriaxone; Escherichia coli; MICs; Bacteremia
JCM Accepts, published online ahead of print on 16 April 2014 J. Clin. Microbiol. doi:10.1128/jcm.00716-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 1 2 Title: Determining
More informationDetection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia coli
ISSN: 2319-7706 Volume 2 Number 8 (2013) pp. 196-205 http://www.ijcmas.com Original Research Article Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia
More informationAbstract. Introduction
ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.02893.x Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin clavulanate and piperacillin tazobactam with extended-spectrum
More informationThe biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush
International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.
More informationBeta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations Dr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology,
More informationWELCOME. to the CDS WORKSHOP
WELCOME to the CDS WORKSHOP Sydney 2010 Excel Spreadsheet for Registration Recent Additions to the CDS Doripenem 10mg disc A carbapenem claimed to be more active against Pseudomonas than Meropenem Daptomycin:
More informationPrevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype
J Antimicrob Chemother 2010; 65: 460 464 doi:10.1093/jac/dkp484 Advance publication 22 January 2010 Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC
More informationReceived 16 September 2005/Accepted 20 September 2005
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2005, p. 5945 5949 Vol. 43, No. 12 0095-1137/05/$08.00 0 doi:10.1128/jcm.43.12.5945 5949.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More information*Kotgire Santosh A and Tankhiwale Nilima. Sciences University Sawangi(M) Wardha, Maharashtra, India *Author for Correspondence
PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF METALLO-β-LACTAMASES (M-β-L) PRODUCING PSEUDOMONAS AREUGINOSA FROM RURAL HOSPITAL: COMPARISON OF TWO DISK DIFFUSION METHODS *Kotgire Santosh A and
More informationInternational Journal of Current Research in Medical Sciences
Int. J. Curr. Res. Med. Sci. (2016). 2(1): 1 10 International Journal of Current Research in Medical Sciences ISSN: 2454-5716 www.ijcrims.com Coden: IJCRPP(USA) Research Article http://s-o-i.org/1.15/ijcrms-2016-2-1-1
More informationFaecal prevalence of extended-spectrum ß-lactamase (ESBL)- producing coliforms in a geriatric population and among haematology patients
Malaysian J Pathol 2005; 27(2) : 75 81 FAECAL ESBL-PRODUCING COLIFORMS Faecal prevalence of extended-spectrum ß-lactamase (ESBL)- producing coliforms in a geriatric population and among haematology patients
More informationPrevalence of AMPC Beta Lactamases among Gram Negative Bacterial Isolates in a Tertiary Care Hospital
ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 219-227 http://www.ijcmas.com Original Research Article Prevalence of AMPC Beta Lactamases among Gram Negative Bacterial Isolates in a Tertiary Care Hospital
More informationExtended Spectrum β-lactamases: Critical Tools of Bacterial Resistance
Review Article Mahidol University Journal of Pharmaceutical Science 2012; 39 (1), 1-8 Extended Spectrum β-lactamases: Critical Tools of Bacterial Resistance Department of Microbiology, Faculty of Pharmacy,
More informationH. Wu, B.-G. Liu, J.-H. Liu, Y.-S. Pan, L. Yuan and G.-Z. Hu
Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province,
More informationINTRODUCTION METHODS Printed in Great Britain. Correspondence Mark A. Fisher
Journal of Medical Microbiology (2009), 58, 774 778 DOI 10.1099/jmm.0.006171-0 Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum
More informationExtended double disc synergy testing reveals a low prevalence of extended-spectrum b-lactamases in Enterobacter spp. in Vienna, Austria
Journal of Antimicrobial Chemotherapy (2007) 59, 854 859 doi:10.1093/jac/dkm060 Advance Access publication 8 March 2007 Extended double disc synergy testing reveals a low prevalence of extended-spectrum
More informationESBLs and KPCs: Impact of Revised CLSI Breakpoints on testing and Reporting Algorithms
ESBLs and KPCs: Impact of Revised CLSI Breakpoints on testing and Reporting Algorithms Stephen G. Jenkins, Ph.D. Director, Clinical Microbiology Laboratories New York/Presbyterian Hospital Weill Cornell
More informationEXTENDED SPECTRUM BETA (Β) LACTAMASES IN CLINICAL ISOLATES OF GRAM-NEGATIVE BACILLI IN AJMAN, UNITED ARAB EMIRATES
GMJ ORIGINAL ARTICLE EXTENDED SPECTRUM BETA (Β) LACTAMASES IN CLINICAL ISOLATES OF GRAM-NEGATIVE BACILLI IN AJMAN, UNITED ARAB EMIRATES Ekta Chourasia, Krishna Pratap Singh, Sudheer Keshav Kher ABSTRACT
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 8, September 2014
EVALUATION OF CHROMAGAR-CTX FOR THE DETECTION OF CTX-M-ESBL- PRODUCING GRAM NEGATIVE BACTERIAL ISOLATES RASHA H. ELSHERIF* LAMIAA A. MADKOUR** REHAM A. DWEDAR*** *Clinical Pathology Department, Faculty
More informationThe occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria by a simple..
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 12 Ver. I (Dec. 2015), PP 19-24 www.iosrjournals.org The occurrence of AmpC β-lactamase and
More informationSusceptibility Tests
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p. 213-217 Vol. 16, No. 2 0095-1137/82/080213-05$02.00/0 In Vitro Studies with Cefotaxime: Disk Diffusion Susceptibility Tests SMITH SHADOMY* AND EDWARD L.
More informationAntimicrobial Susceptibility Testing Disk Diffusion
Antimicrobial Susceptibility Testing Disk Diffusion Babak Valizadeh,DCLS Babak_Valizadeh@hotmail.com 1390 / 09 / 10 2011.12.01 1 2 3 CLSI - M02-A10 / 2009 4 CLSI M100-S21 / 2011 Antimicrobial Susceptibility
More informationChapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method)
Chapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method) The disk diffusion method presented in this chapter has been carefully standardized by the National Committee for Clinical Laboratory
More informationDrug Susceptibility Pattern of Extraintestinal Pathogenic E.Coli Isolated from Various Clinical Specimens
International Journal of Research Studies in Microbiology and Biotechnology (IJRSMB) Volume 2, Issue 1, 2016, PP 22-27 ISSN 2454-9428 (Online) www.arcjournals.org Drug Susceptibility Pattern of Extraintestinal
More informationCharacterization of Clinical Isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum -Lactamase Detection Method
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2003, p. 1463 1468 Vol. 41, No. 4 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.4.1463 1468.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationExtended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system
Journal of Medical Microbiology (2011), 60, 756 760 DOI 10.1099/jmm.0.024075-0 Extended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system Maria José Espinar,
More informationCharacterization, Antibiotic Resistance Pattern and Detection of Metalloβ-lactamases and Amp C in Pseudomonas aeruginosa in a Tertiary Care Hospital
Original Research Characterization, Antibiotic Resistance Pattern and Detection of Metalloβ-lactamases and Amp C in Pseudomonas aeruginosa in a Tertiary Care Hospital Amit Rajshekar Ugargol 1, Shilpa Karnum
More informationReceived 17 September 2008/Returned for modification 29 October 2008/Accepted 18 November 2008
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2009, p. 294 299 Vol. 47, No. 2 0095-1137/09/$08.00 0 doi:10.1128/jcm.01797-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Identification
More informationScreening for Resistant Organisms and Infection Control
Screening for Resistant Organisms and Infection Control Dr Sonal Saxena Professor Department of Microbiology Lady Hardinge Medical College New Delhi 1 MDRO The proportion of K. pneumoniae and E. coli with
More informationA Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae
A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease
More informationA Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1
A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease
More informationJOHN DEMPSEY HOSPITAL Farmington, Connecticut ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates
JOHN DEMPSEY HOSPITAL Farmington, Connecticut 2017 ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates **GROUPED BY CULTURE SOURCES** (data from 1/1/17 1/1/18) Prepared by: UCHC/JDH Antimicrobial
More informationRole of inducers in detection of bla PDC resistance in Pseudomonas aeruginosa
Indian J Med Res 145, May 2017, pp 659-664 DOI: 10.4103/ijmr.IJMR_628_15 Quick Response Code: Role of inducers in detection of bla PDC -mediated oxyiminocephalosporin resistance in Pseudomonas aeruginosa
More informationCRE Laboratory Testing and CRE Lab Testing Recommendations in-depth recommendations on CRE laboratory detection
December 2014 Dear Laboratory Director, The Illinois Department of Public Health (IDPH) amended the Control of Communicable Diseases Code (77 Ill. Adm. Code 690) to require reporting of Carbapenem-Resistant
More informationLauren A. Darling1#, Ann M. Evans1, Kathleen A. Stellrecht1,2, Seela M. Nattanmai1,
JCM Accepted Manuscript Posted Online 20 September 2017 J. Clin. Microbiol. doi:10.1128/jcm.01185-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 JCM Letter to the Editor Submission
More informationOngoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
Journal of Antimicrobial Chemotherapy (2008) 61, 59 63 doi:10.1093/jac/dkm443 Advance Access publication 13 November 2007 Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece:
More informationTitle: Description of the First Escherichia coli Clinical Isolate Harboring Colistin-
AAC Accepted Manuscript Posted Online 24 October 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01945-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 Title: Description
More informationThe Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics in Klebsiella pneumoniae isolates from clinical samples and plasmid curing
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 11:557-561 The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics
More informationNew Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized patients: A pilot study
Indian J Med Res 146, July 2017, pp 105-110 DOI: 10.4103/ijmr.IJMR_594_15 Quick Response Code: New Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized
More informationInvestigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing
Investigational New Drug - Groundwork for in vitro antimicrobial susceptibility testing Erika Matuschek, Ph D Lead Scientist/Operational Manager EUCAST Development Laboratory (EDL) Växjö, Sweden ASM/ESCMID
More informationDetection and characterization of metallo-β-lactamases producing Pseudomonas aeruginosa clinical isolates at a tertiary care hospital of Bhopal, India
International Journal of Research in Medical Sciences Mehta A et al. Int J Res Med Sci. 2016 Sep;4(9):4084-4088 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrmss20162938
More informationOXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan
OXA-type J Microbiol ESBLs Immunol in P. Infect aeruginosa 2006;39:130-134 OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital
More informationVariable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum β-lactamases
Journal of Antimicrobial Chemotherapy (2003) 51, 605 612 DOI: 10.1093/jac/dkg114 Advance Access publication 28 January 2003 Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More informationInternational Journal of Pharma and Bio Sciences
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIBIOTIC SUSCEPTIBILITY PROFILE AND ITS CORRELATION TO BIOFILM FORMATION AND MANNOSE RESISTANT HEMAGGLUTINATION
More informationEvaluation of the NCCLS Extended-Spectrum -Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 3142 3146 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.3142 3146.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationEvaluation of the NCCLS Extended-Spectrum -Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 3142 3146 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.3142 3146.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationNordicAST Bacteroides AST Study 2018
NordicAST Bacteroides AST Study 2018 Background Bacteroides fragilis is the most common anaerobic species causing invasive infections (1). In addition to possessing intrinsic resistance mechanisms against
More informationComparison of different methods of determining b-lactam susceptibility in clinical strains of Pseudomonas aeruginosa
Journal of Medical Microbiology (2009), 58, 625 629 DOI 10.1099/jmm.0.005587-0 Comparison of different methods of determining b-lactam susceptibility in clinical strains of Pseudomonas aeruginosa Eva Torres,
More informationExtended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia
Current Research in Microbiology Original Research Paper Extended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia 1 Viera
More informationReceived 6 July 2004; returned 14 August 2004; revised 6 September 2004; accepted 8 September 2004
Journal of Antimicrobial Chemotherapy (2004) 54, 870 875 DOI: 10.1093/jac/dkh449 Advance Access publication 7 October 2004 Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum
More information64 Mukherjee et al. Int. J. Biosci. 2011
RESEARCH PAPER OPEN ACCESS Detection of blatem and blactx-m genes by multiplex polymerase chain reaction amongst uropathogenic Escherichia coli strains isolated from hospitalized patients in Kolkata, India
More informationResistance, Yonsei University College of Medicine, Seoul, Korea; and 2 Department of
AAC Accepts, published online ahead of print on March 0 Antimicrob. Agents Chemother. doi:./aac.0- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationAccurate and Timely Identification of Genes Conferring Resistance to Carbapenems Serves as an Important Tool for Infection Control Measures
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.296
More informationEducational Workshops 2016
Educational Workshops 2016 Case One: Outbreak of CPE We are grateful to Suzy Fitzgerald, Consultant Microbiologist, St Vincent s University Hospital, Dublin for composing this case. 2011 Spring 2011 Sporadic
More informationOriginal Article Detection of integrons in Escherichia coli producing plasmid-mediated AmpC β-lactamases
Int J Clin Exp Med 2019;12(2):1690-1696 www.ijcem.com /ISSN:1940-5901/IJCEM0079457 Original Article Detection of integrons in Escherichia coli producing plasmid-mediated AmpC β-lactamases Juanjuan Ding,
More informationAvailable online at journal homepage:
Journal of Microbiology, Immunology and Infection (2012) 45, 193e199 Available online at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Laboratory identification, risk factors,
More informationVerification of Disk Diffusion Tests
Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of
More informationOriginal Research article Prevalence of Metallo-betalactamases (MBL) producing Pseudomonas aeruginosa in a Tertiary care Hospital.
Original Research article Prevalence of Metallo-betalactamases (MBL) producing Pseudomonas aeruginosa in a Tertiary care Hospital. Dr Anil Rajput*, Dr Bhavin Prajapati **, Dr.Bimal Chauhan***, Dr Atit
More informationCombatting AMR: diagnostics
Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International
More informationAdvances in Life Science and Technology ISSN (Paper) ISSN X (Online) Vol.13, 2013
The Reliability of Using Vitek 2 Compact System to Detect Extended-Spectrum Beta-lactamase-producing Isolates in Escherichia coli and Klebsiella pneumoniae in Accra, Ghana *Henry Kwadwo Hackman 1, George
More informationDisk Diffusion Method for Susceptibility Testing of
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1991, p. 1604-1609 0095-1137/91/081604-06$02.00/0 Copyright 1991, American Society for Microbiology Vol. 29, No. 8 Disk Diffusion Method for Susceptibility Testing
More informationOriginal Article. Extended spectrum Beta lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi centric Study Across Karnataka
Original Article Extended spectrum Beta lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi centric Study Across Karnataka Sridhar PN Rao, Prasad Subba Rama 1, Vishwanath Gurushanthappa,
More informationPREVALENCE OF EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING PROTEUS IN RAW MILK, MILK PRODUCTS AND UTI PATIENTS
PREVALENCE OF EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING PROTEUS IN RAW MILK, MILK PRODUCTS AND UTI PATIENTS *Syed Waseem Sajad Department of Microbiology, Singhania University, Jhunjhunu, Rajasthan India
More informationM. Ben-David 1, O. Hammer 1, A.Shinderman 1, Y. Gluckman- Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2
437 Fast Antibiotic Susceptibility Testing Utilizing a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow Cytometry M. Ben-David 1, O. Hammer 1, A.Shinderman
More informationMIC & Etest. Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences
MIC & Etest Dr. M. Talebi Ph.D of Bacteriology Tehran University of Medical Sciences MIC The minimum inhibitory concentration (MIC) is defined as the lowest concentration of the antimicrobial agent required
More informationPrevalence of Metallo-beta-lactamase Production in Imipenem-resistant Pseudomonas in Tertiary Care Center at Kota Region
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/325 Prevalence of Metallo-beta-lactamase Production in Imipenem-resistant in Tertiary Care Center at Kota Region Anita
More informationPhenotypic and Genotypic Detection of Metallo-Beta-Lactamases among Imipenem Resistant Gram Negative Isolates
Phenotypic and Genotypic Detection of Metallo-Beta-Lactamases among Imipenem Resistant Gram Negative Isolates Mohammad Mohammadzadeh 1*, Mahnaz Tavakoli 1, Abolfazl Mohebi 2, Samad Aghayi 2 1 Department
More informationReceived 4 December 1996/Returned for modification 17 March 1997/Accepted 21 May 1997
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1997, p. 2191 2197 Vol. 35, No. 9 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Comparison of Screening Methods for Detection of Extended-
More informationResearch Article Emerging Perils of Extended Spectrum β-lactamase Producing Enterobacteriaceae Clinical Isolates in a Teaching Hospital of Nepal
BioMed Research International Volume 2016, Article ID 1782835, 7 pages http://dx.doi.org/10.1155/2016/1782835 Research Article Emerging Perils of Extended Spectrum β-lactamase Producing Enterobacteriaceae
More informationEvaluation of the Osiris Expert System for Identification of -Lactam Phenotypes in Isolates of Pseudomonas aeruginosa
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2003, p. 3712 3718 Vol. 41, No. 8 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.8.3712 3718.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationINNOVATIVE SCIENCE DRIVES ANTIBIOTIC LEADERSHIP. Corporate Presentation October 2018 Nasdaq: AKAO
INNOVATIVE SCIENCE DRIVES ANTIBIOTIC LEADERSHIP Corporate Presentation October 2018 Nasdaq: AKAO Forward Looking Statements This presentation contains forward-looking statements. All statements other than
More informationABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18
M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,
More informationPrevalence of SHV β-lactamases in Escherichia coli
African Journal of Microbiology Research Vol. 6(26), pp. 5518-5522, 12 July, 2012 Available online at http://www.academicjournals.org/ajmr DOI: 10.5897/AJMR12.1228 ISSN 1996-0808 2012 Academic Journals
More informationEzy MIC Strip FEATURES AND ADVANTAGES
Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal
More informationExtended-spectrum b-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae
Volume 7 Number 3 (June 2015) 144-149 ORIGINAL ARTICLE Extended-spectrum b-lactamase and carbapenemase production among burn and non-burn clinical isolates of Klebsiella pneumoniae Fereshteh Eftekhar *,
More informationExtended-Spectrum -Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2001, p. 933 951 Vol. 14, No. 4 0893-8512/01/$04.00 0 DOI: 10.1128/CMR.14.4.933 951.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Extended-Spectrum
More informationInt.J.Curr.Microbiol.App.Sci (2016) 5(4):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 4 (2016) pp. 133-139 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.504.018
More informationSamples across Bangladesh
Research Article imedpub Journals http://www.imedpub.com/ ARCHIVES OF CLINICAL MICROBIOLOGY Abstract Bacteriological Quality of Drinking Water Samples across Bangladesh A total of 106 (tube well, deep
More information1. Procedure for Antibiotic susceptibility test by disc diffusion analysis
Nanoparticles Functionalized with Ampicillin Destroy Multiple Antibiotic Resistant Isolates of Pseudomonas aeruginosa, Enterobacter aerogenes and Methicillin Resistant Staphylococcus aureus Ashley Brown
More informationIsolation of bacteria from diabetic foot ulcers with special reference to anaerobe isolation by simple two-step combustion technique in candle jar
Indian J Med Res 145, January 2017, pp 97-101 DOI: 10.4103/ijmr.IJMR_1436_14 Quick Response Code: Isolation of bacteria from diabetic foot ulcers with special reference to anaerobe isolation by simple
More informationPrevalence of CTX-M Genes in Bacterial Strain Isolated from Patients Hospitalized in ICU Units in the City of Qom, Iran
Prevalence of CTX-M Genes in Bacterial Strain Isolated from Patients Hospitalized in ICU Units in the City of Qom, Iran Yaser Sharifi 1, 2, 3, Abbas Morovvati 1, Azadeh Abedzadeh 1, Ali Javadi 4 * 1 Department
More informationIMPLEMENTATION OF EUCAST BREAKPOINTS
IMPLEMENTATION OF EUCAST BREAKPOINTS BELGIAN /GDL COUNTDOWN UNTIL 1ST JANUARY 2010 : 64 DAYS Pierrette Melin, CHU of Liege Coordinator of the SBIMC-BVIKM/EUCAST microbiology working party 1 Introduction
More informationPharmacodynamics of Ampicillin-Sulbactam in an In Vitro Infection Model against Escherichia coli Strains with Various Levels of Resistance
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1998, p. 231 235 Vol. 42, No. 2 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Pharmacodynamics of Ampicillin-Sulbactam in an In Vitro
More informationANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED
ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED Romney Humphries, Ph.D., DABMM Section Chief, Clinical Microbiology University of California Los Angeles Lost Angeles, CA Susan E. Sharp, Ph.D., DABMM, FAAM
More informationDirect Susceptibility Testing with Positive BacT/Alert Blood Cultures by Using MicroScan Overnight and Rapid Panels
JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p. 2052 2056 Vol. 36, No. 7 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Direct Susceptibility Testing with
More informationDirect Susceptibility Testing with Positive BacT/Alert Blood Cultures by Using MicroScan Overnight and Rapid Panels
JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p. 2052 2056 Vol. 36, No. 7 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Direct Susceptibility Testing with
More informationDirect Susceptibility Testing with Positive BacT/Alert Blood Cultures by Using MicroScan Overnight and Rapid Panels
JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p. 2052 2056 Vol. 36, No. 7 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Direct Susceptibility Testing with
More information